Biogen BIIB
NASDAQ BIIB
$250.69 -3.15 (-1.24%)
At close: Oct 23, 2026 · 4:00 PM EDT

Biogen (BIIB) Non-Current Deferred Tax Liability (2009 - 2026)

Updated

Biogen's Non-Current Deferred Tax Liability was $945.5 million in Q2 2026, up 699.2% from $118.3 million a year earlier and up 95.6% from the prior quarter.

Analysis

Biogen (BIIB) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Deferred Tax Liability at Biogen came in at $507.6 million, up 166.5% from FY2024.

  • Non-Current Deferred Tax Liability shows a five-year compound annual growth rate of -13.2% (FY2020 to FY2025).
  • In earlier years, Non-Current Deferred Tax Liability was $190.5 million in FY2024 (-70.3%), $641.8 million in FY2023 (+91.8%), $334.7 million in FY2022 (-51.8%) and $694.5 million in FY2021 (-32.8%).
  • The Q2 2026 figure marks the highest quarterly Non-Current Deferred Tax Liability since Q1 2021.
  • Compared with a year earlier, Non-Current Deferred Tax Liability has increased for three straight quarters, with growth averaging 107.6% over the last eight quarters.
  • The best year-over-year quarter for Non-Current Deferred Tax Liability over five years was Q2 2026 (growth of 699.2%); the worst was Q2 2025 (a decline of 80.0%).
  • Per Business Quant data, BIIB's Non-Current Deferred Tax Liability in the three quarters before Q2 2026 was $483.5 million (Q1 2026), $507.6 million (Q4 2025) and $358.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Biogen 37.04 Bn 23.70 Bn 1.96 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 945.50 Mn
Mar 31, 2026 483.50 Mn
Dec 31, 2025 507.60 Mn
Sep 30, 2025 358.10 Mn
Jun 30, 2025 118.30 Mn
Mar 31, 2025 133.20 Mn
Dec 31, 2024 190.50 Mn
Sep 30, 2024 882.40 Mn
Jun 30, 2024 590.60 Mn
Mar 31, 2024 658.10 Mn
Dec 31, 2023 641.80 Mn
Sep 30, 2023 728.10 Mn
Jun 30, 2023 143.90 Mn
Mar 31, 2023 251.30 Mn
Dec 31, 2022 334.70 Mn
Sep 30, 2022 328.90 Mn
Jun 30, 2022 480.60 Mn
Mar 31, 2022 571.20 Mn
Dec 31, 2021 694.50 Mn
Sep 30, 2021 774.70 Mn
API Access

Biogen Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=BIIB&period=max&api_key=YOUR_API_KEY